Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference
Viatris (Nasdaq: VTRS) will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Viatris (Nasdaq: VTRS) will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 13, 2026. The company's presentation and fireside chat begin at 9:00 a.m. PT / 12:00 p.m. ET. A live webcast will stream at investor.viatris.com, and an archived recording will be available at the same location for a limited time after the event.
Details
News Market Reaction – VTRS
On Dec 17, the day this news came out, VTRS closed 2.09% above the previous close.
Data tracked by StockTitan Argus for the Dec 17 session.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference
- Conference date
- Jan. 13, 2026
- Scheduled presentation in San Francisco
- Presentation time PT
- 9 a.m. PT
- Start time for presentation and fireside chat
- Presentation time ET
- 12 p.m. ET
- Start time for presentation and fireside chat
Historical Context
-
Scheduled fireside chats at two early-December healthcare investor conferences.
-
Named to Fortune World’s Best Workplaces 2025 list highlighting culture and inclusion.
-
Reported Q3 2025 results with flat revenue, lower EPS, and raised guidance ranges.
-
Board declared a $0.12 per-share quarterly dividend with December 2025 payment date.
-
Collaboration with Locus Biosciences on phage therapies for ophthalmic infections.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live webcast of the event can be found at investor.viatris.com. An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time.
About Viatris
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302643963.html
SOURCE Viatris Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.